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Abstract
Background: Delirium in critically ill patients has a strong adverse impact on prognosis. In spite of its recognized
importance, however, delirium screening and treatment procedures are often not in accordance with current
guidelines. This implementation study is designed to assess barriers and facilitators for guideline adherence and
next to develop a multifaceted tailored implementation strategy. Effects of this strategy on guideline adherence as
well as important clinical outcomes will be described.
Methods: Current practices and guideline deviations will be assessed in a prospective baseline measurement.
Barriers and facilitators will be identified from a survey among intensive care health care professionals (intensivists
and nurses) and focus group interviews with selected health care professionals (n = 60). Findings will serve as a
foundation for a tailored guideline implementation strategy. Adherence to the guideline and effects of the
implementation strategies on relevant clinical outcomes will be piloted in a before-after study in six intensive care
units (ICUs) in the southwest Netherlands. The primary outcomes are adherence to screening and treatment in line
with the Dutch ICU delirium guideline. Secondary outcomes are process measures (e.g. attendance to training
and knowledge) and clinical outcomes (e.g. incidence of delirium, hospital-mortality changes, and length of stay).
Primary and secondary outcome data will be collected at four time points including at least 924 patients.
Furthermore, a process evaluation will be done, including an economical evaluation.
Discussion: Little is known on effective implementation of delirium management in the critically ill. The proposed
multifaceted implementation strategy is expected to improve process measures such as screening adherence in
line with the guideline and may improve clinical outcomes, such as mortality and length of stay. This ICU Delirium
in Clinical Practice Implementation Evaluation study (iDECePTIvE-study) will generate important knowledge for ICU
health care providers on how to improve their clinical practice to establish optimum care for delirious patients.
Trials registration: Clinical Trials NCT01952899
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Background
Delirium, also known as ‘brain failure’, is a common form
of vital organ failure in critically ill patients. It has an acute
onset and is characterized by a combination of attention
and cognitive deficits and a fluctuating consciousness
[1]. Disturbed motor activity (apathy or agitation), visual
hallucinations, and sleep disruption are among the most
frequently observed symptoms. The reported incidence
of delirium in critically ill patients ranges from 16%–89%,
depending on type of intensive care unit (ICU), method
of assessment, and patient population [2]. Delirium is
especially common in over 65-year-old patients [3,4].
Delirium is an important, independent predictor of mor-
tality [5-7]. Critically ill patients may develop delirium-
associated complications leading to serious self-harm,
such as attempting to remove the endotracheal tube,
central lines and catheters, or falling out of bed [8]. Many
delirious patients show severe psychological distress and
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anxiety [8]. Delirium is a cause of longer ICU and hospital
stay, and affected patients have more long-term morbidity
[2,5] and a worse prognosis after discharge compared
with non-delirious ICU patients. The duration of delirium
is also an important prognostic indicator for various
adverse outcomes. Furthermore, recent research suggests
that ICU delirium independently predicts long-term cog-
nitive impairment comparable to mild Alzheimer’s disease
[5,7,9-14]. The sequelae associated with delirium are a
cause of increased health care costs [15].
Therefore, delirium in these critically ill patients requires
adequate management, including systematic screening to
prevent that the diagnosis is missed in patients who
display only subtle signs of delirium (‘hypoactive delirium’)
[16]. The importance of routine screening for delirium at
the ICU was already advocated in the clinical practice
guidelines for pain and sedation issued in 2002 by the
American College of Critical Care Medicine (ACCM)/
Society of Critical Care Medicine (SCCM) [17] but delir-
ium screening has not yet been widely adopted [18].
The Netherlands Society for Intensive Care (NVIC)
developed and authorized a delirium guideline in 2010
[19]. The recently published ‘Clinical Practice Guidelines
for the Management of Pain, Agitation and Delirium
(PAD) in the ICU’ from ACCM/SCCM [20] are generally
in line with this guideline. Both guidelines recommend
routine delirium screening in critically ill patients using
a valid and reliable screening tool. Despite this, a vali-
dated delirium screening tool is not routinely used in
most Dutch ICUs; the management of delirium strongly
depends on local policy and is generally not in line with
current recommendations [16,21]. The Netherlands is
not alone in this respect; also in other countries, the at-
tention paid to the monitoring and management of ICU
delirium has been shown to be insufficient [18].
‘Get With The Guidelines’ initiatives have the potential
to accomplish practice changes in the ICU environment
that may result in improved clinical outcomes, including
mortality [22]. However, the most effective way to trans-
late such ‘paper’ guidelines to real-life clinical practice is
not clear. In general, a variety of barriers may be in the
way of good adherence to guidelines and interventions
[23-25]. Hence, it is necessary to develop a tailored im-
plementation strategy based on a thorough analysis of
the context and target group [24].
Objective
We designed the ICU Delirium in Clinical Practice Imple-
mentation Evaluation (iDECePTIvE) study with the fol-
lowing aims: 1) to assess the barriers and facilitators for
adherence to the Dutch ICU delirium guideline [19];
2) based on these results, to develop a tailored implemen-
tation strategy targeting these influencing factors for suc-
cessful implementation and long-term adherence to the
guideline; and 3) to study the effects of tailored implemen-
tation on adherence to the guideline, clinical outcome,
and costs in a prospective multi-center study.
The following research questions are addressed to an-
swer these aims:
1. What are the current practices (before-implementation)
with regard to delirium management and degrees of
adherence to the delirium guideline in the
participating ICUs?
2. What are the influencing factors (barriers and
facilitators) for the implementation of the ICU
delirium guideline in the ICUs as reported by
intensivists, ICU nurses, and psychiatrists?
3. What should be the content of a tailored
implementation strategy to improve adherence to
the delirium guideline based on the answers to the
first two questions?
4. What is the effect of the tailored implementation
strategy on guideline adherence, knowledge of health
care providers, delirium incidence, clinical outcomes
(mortality, length of ICU stay) and health care costs?
5. What are potential explanations for why the
intervention was effective or not, based on ICU and
health care providers’ characteristics indicative of
local ‘culture?’
Methods
The iDECePTIvE study is a descriptive, explorative pro-
spective multi-center study, using a mixed method de-
sign in six ICUs in the southwest of the Netherlands. In
line with the research questions, we designed the study
in several phases (see detailed schedule in Figure 1):
A. Analysis of the current practice of delirium
management and level of adherence to the Dutch
NVIC delirium guideline in the participating ICUs.
B. Identification of barriers and facilitators for the
implementation of the ICU delirium guideline.
C. Development of a tailored implementation strategy
based on the results of phases A and B.
D. Implementation of the guideline and measurement
of the effects.
We describe the methods, population, analysis, and out-
comes per study phase. An overview is given in Table 1
and Figure 1.
Study sites and participants
The study will be performed in six ICUs of university,
non-university-teaching, and non-university-non-teach-
ing hospitals. Wards were selected to include several
levels of intensity of intensive care practice. Inclusion
criteria for patients are: age ≥18 years and admitted to
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an ICU for ≥24 h. Involved professionals are all ICU
physicians and nurses.
Phase A: analysis of current practice of delirium management
and adherence to the Dutch delirium guideline
Study design and population
Over a 4-month period, we will prospectively record the
incidences of delirium, frequency of delirium assessments,
types of pharmacological and non-pharmacological treat-
ments, and documented preventive interventions. Unit staff
will not be actively informed about the study, nor will they
be educated on delirium, so as to avoid a Hawthorne effect
as much as possible. The results of this analysis will serve
as a baseline measure to compare future practice and out-
come changes in the course of the implementation project.
Measures
Adherence to and deviation from the delirium guideline
will be assessed using the following indicators. The primary
outcome in this study phase is the percentage of patients
screened with either the Confusion Assessment Method for
the Intensive Care Unit (CAM-ICU) [26] or the Intensive
Care Delirium Symptoms Checklist (ICDSC) [27], which
both are validated for use in the ICU. Adherence is defined
as screening of every eligible patient at least once per nurs-
ing shift (i.e. three times daily). The secondary outcomes
are pharmacological treatment with haloperidol or other
antipsychotic drugs; documented psycho-hygiene measures
aimed at preventing delirium (such as use of hearing aids
or glasses and stimulating a proper night-day rhythm; early
mobilization and physiotherapy). Delirium is defined either
as a positive CAM-ICU or ICDSC score, or if a screening
tool is not used, pragmatically defined as 1) administration
of haloperidol or other antipsychotic drug; or 2) delirium
reported by a physician or ICU nurse in the patient record,
as confirmed by a designated research nurse on site. Data
on adherence to these indicators for all ICU patients will be
collected by various methods: direct observations and sys-
tematic registration in the patient data management system,
medical records, and 24-h ICU-care lists.
Analysis
Descriptive statistics will be used to describe the out-
comes. Multivariate analysis serves to compare ICUs
Figure 1 Study schedule.
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regarding patient mix (e.g. age, diagnosis, severity of illness
[Acute Physiology and Chronic Health Evaluation, APA-
CHE II score]) and ICU level of care. The incidence of
delirium will be calculated based on screening (CAM-ICU
or ICDSC) and medical notes (physicians and nurses) and
consulting experts (psychiatrist, geriatrists, or neurologist).
Phase B: identification of barriers and facilitators for the
implementation of the ICU delirium guideline
Study design
Barriers and facilitators will be identified with quantita-
tive and qualitative research methods: 1) a survey and
2) in-depth focus group interviews. The main aim is to
understand, and where possible explain, the opinions, atti-
tudes, beliefs, and perceived practices of health care profes-
sionals with regard to delirium in critically ill patients [28].
Survey
ICU physicians and ICU nurses will be surveyed on their
beliefs, attitudes, and practices regarding the incidence,
clinical relevance, screening for, treatment, and preven-
tion of delirium. The survey will be partly based on the
instrument developed by Ely et al. [29] and expanded
with self-developed questions on non-pharmacological
and preventive interventions for delirium. Furthermore,
the questionnaire will contain statements about the
Table 1 Overview of study phases
Phase Research question Methods Target population/data
resource
Measures
A What are the current practices
(before-implementation) and
the adherence to the delirium
guideline in the participating
ICUs?
Prospective, descriptive
study, analyzing variation
of care
Data from 6 ICUs Indicators e.g.:
-Adherence to delirium screening
-Incidence of delirium
-Pharmacological treatment
-Sedation practices
-Non-pharmacological treatment
-Knowledge
B What are the influencing
factors (barriers and facilitators)
for the implementation of the
Dutch ICU delirium guideline
by intensivists, ICU nurses, and
psychiatrists?
Survey on knowledge, attitudes
and perceptions, and structured
focus group interviews
Health care professionals:
intensivists, residents, ICU
nurses, managers and
psychiatrists, geriatrist
or neurologist
Barriers and facilitators classified as
related to: 1) guideline; 2) provider
characteristics (e.g. knowledge and
attitudes); 3) institutional characteristics
(e.g. organization, structure, resources);
4) implementation (e.g. how and to
what extent the guideline is
implemented); 5) patient characteristics;
and 6) social context (e.g. ICU culture).
C What is the content of a
tailored strategy to improve
the adherence to the delirium
guideline?
Strategy development
according to implementation
frameworks by Grol and
Wensing, and Cabana
Matching the data from the
current practice, questionnaires
and focus groups and
questionnaires to construct
effective implementation
strategies from the literature
Tailored multifaceted implementation
strategy to effectively implement
current guideline based delirium
management
D What is the effect of the
tailored implementation
strategy on guideline
adherence, knowledge of
health care providers, delirium
incidence, clinical outcomes
(mortality, length of stay) and
health care costs?
Prospective before-after study Data from 6 ICUs (Process) indicators e.g.:
-Adherence delirium screening
-Incidence of delirium
-Pharmacological treatment
-Non-pharmacological treatment
-Knowledge
Outcomes e.g.:
-Length of stay
-Hospital mortality
Costs
D Explore potential explanations
for why the intervention was
effective or not based on ICU
and health care providers’
characteristics indicative of
local “culture”.
Process evaluation: qualitative
(outcomes,) and quantitative
data (survey and interviews)
Data from 6 ICUs. Frame work
for process evaluation, matching
outcomes with actual exposure,
and experiences of the
implementation strategy
Underlying mechanisms that explain
the effects of the study.
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delirium guideline and attitude towards guidelines in gen-
eral [30] and questions assessing knowledge [29,31,32]
and demographic characteristics of responders. The survey
will be repeated in a later phase (D, after implementation)
to assess impact of implementation on attitudes and prac-
tice perceptions.
Focus group interviews
The uniqueness of a focus group interview is its ability to
generate data based on the synergy of group interaction.
This type of analysis is also essential to understand the
potential barriers and facilitators in the collaboration be-
tween health care professionals, e.g. nurses and physicians.
An interview framework and protocol will be developed
with a series of open-ended questions, based on the frame-
work of knowledge-attitude-behavior related barriers for
guideline adherence of Cabana et al. [23]; the interdiscip-
linary conceptual framework of clinicians’ compliance with
guidelines of Gurses et al. [33]; and the framework for ad-
herence to clinical practice guidelines in the ICU of Cahill
et al. [34]. These frameworks distinguish six major categor-
ies of factors that influence adherence to evidence-based
guidelines: 1) the guideline; 2) the health professionals’
characteristics (e.g. knowledge and attitudes); 3) the institu-
tional characteristics (e.g. organization, structure, re-
sources); 4) the implementation (e.g. how the guideline is
implemented); 5) the patient characteristics; and 6) the so-
cial context (e.g. ICU culture). The survey findings will be
discussed in the focus group interviews to explore discrep-
ancies between professionals’ beliefs and daily practices.
Study population
All health professionals in the six ICUs, including ICU
nurses, intensivists, residents, and psychiatrists or geria-
trists, will be asked to complete an online survey.
For the focus group interviews, we will purposefully se-
lect 8–10 professionals involved in delirium care from each
participating ICU, e.g. intensivists, residents, ICU nurses,
managers and psychiatrists, geriatrist, or neurologist.
Outcome measures
Barriers and facilitators for adherence to the delirium
guideline in daily practice will be classified according to
the six major categories of the above-mentioned frame-
works [23,33,34]. Combining the findings on current
practices (phase A) with the results of the surveys and
focus group interviews (phase B) will give a complete
overview of current practices, attitudes, and perceptions
at baseline of the study and potential barriers and facili-
tators for implementing the guideline.
Analysis
The different barriers and facilitators will be quantified
and expressed in percentages. Continuous data will be
presented as means (+/−SD), non-normally distributed
as medians (interquartile range). Differences among the
health care professionals and across the six ICUs will be
evaluated with ANOVA or Kruskall–Wallis test depend-
ing on normality of data distributed. Data will be ana-
lyzed using IBM SPSS version 21.0.
The focus group interviews will be audiotaped and tran-
scribed in full for analysis. Qualitative analysis will be done
with the software package Atlas.ti using Krueger’s frame-
work analysis approach, which provides a clear series of
steps: familiarization, identifying a thematic framework,
indexing, charting, and mapping and interpretation [35].
To strengthen validity of the analysis, participants will be
invited to provide feedback on a summary of the focus
group interview.
Phase C: development of the tailored implementation
strategy
The implementation model of Grol et al. [24] assumes
that the effectiveness of the implementation is enhanced
if the chosen strategy is appropriate to the innovation,
the setting and target group, and includes an assessment
of current practice and of barriers and facilitators for
guideline adherence [36]. In this study, we will use this
model, which includes several steps. Step 1 involves the
development and clear description of the recommended
performance. Steps 2 and 3 analyze the setting and
target group. Both current practice and the barriers and
facilitators for guideline adherence are explored in these
steps. Step 4 involves developing and choosing strategies
and measures to change practice that target the pre-
viously identified barriers and facilitators. Steps 5 and 6
subsequently develop and apply the implementation to
integrate changes in routine of care, and step 7 evaluates
the implementation strategy [24].
Based on the results of phases A and B, a team of imple-
mentation experts, investigators, and clinicians (nurses
and physicians) will develop a tailored strategy for im-
plementation aimed at enhanced delirium guideline
adherence, focusing on the barriers and facilitators most
frequently encountered. The strategy should facilitate inte-
gration of the guideline in daily practice and its sustained
use over time. The expert team will discuss the content of
the tailored implementation strategy with local ICU teams.
Two main questions should be answered in this setting:
1) Can the barriers and facilitators found be successfully
translated into tailored implementation interventions?;
and 2) Are the tailored interventions applicable in daily
practice? Finally, the implementation expert team will
adapt the tailored strategy based on feedback provided by
the local ICU teams.
Tailored multifaceted strategies are likely to be more
effective than single strategies [36]. Barriers and facilita-
tors are expected to exist at different levels. This means
Ista et al. Implementation Science 2014, 9:143 Page 5 of 10
http://www.implementationscience.com/content/9/1/143
that the tailored strategy will consist of a combination
of different interventions targeted to influence the pro-
fessionals, the organization, and the structure of care.
To strengthen the strategy development, we will be
building upon existing theories for behavioral change
like social learning or social influencing theories [37,38].
Finally, the selected implementation interventions will
be matched to evidence-based interventions, described
by the EPOC taxonomy [39]. We give some examples to
illustrate our approach. Possible barriers at a profes-
sional level are aspects of hierarchy and lack of collabor-
ation between nurses and doctors. A physician may have
doubts and not start treatment after an ICU nurse has
identified a delirious patient. This may discourage nurses
to screen for delirium on a daily basis. A consistent
management protocol could properly remove this barrier
by linking screening results to a treatment. Another po-
tential barrier is the perceived time-consuming nature of
routine screening. ICT solutions to facilitate registration
could be helpful in this regard.
Phase D: implementation study
Study design and population
The impact of implementation of a delirium guideline in
six ICUs for adults will be studied in a pilot feasibility
study using a prospective multi-center before-after study
design (Figure 1). The primary aim will be to evaluate to
what extent a guideline implementation program can
achieve changes in ICU professionals’ clinical practice
with regard to delirious patients. This will be measured
by the degree of adherence to the guideline recommen-
dations. A secondary aim will be to evaluate the impact
of the implementation interventions on clinical out-
comes (hospital mortality and length of stay at ICU) and
costs of the implementation and whether these may be
linked to the practice changes achieved. A before-after
study is considered a useful instrument, particularly for
pilot studies in which interventions are initially evalu-
ated and refined if necessary before the testing of the
implementation strategy on a wider scale is justified.
Implementation of the delirium guideline will be two-
phased. First, we will implement delirium screening with
the CAM-ICU or ICDSC. This is an essential first step
because prevention and treatment of delirium will only
be possible after adequate and early recognition. Second,
protocolled prevention and treatment interventions
(pharmacological and non-pharmacological) will be im-
plemented. ICUs will be free to select either tool based
on local preference.
Before period—intermediate period—after period
We have defined three periods (see Figure 1). The first
is the four-month before period, during which delirium
will be assessed as described earlier (phase A, current
practice evaluation), i.e. on the basis of antipsychotic
drug therapy and documented delirium diagnosis as a
proxy for delirium incidence when no systematic screen-
ing is performed. The second period is the four-month
intermediate period after implementation of delirium
screening with the CAM-ICU or ICDSC. The same data
as in the before period will be collected, and in addition
delirium incidence as measured with the CAM-ICU or
ICDSC. This period serves to assess the impact of the
barrier analysis (phases A and B) and screening imple-
mentation without formal implementation of a preven-
tion and management protocol. The third period is the
after period, in which the process measures (adherence
to screening, prevention, and pharmacological and non-
pharmacological) and clinical outcomes will be studied
in two successive four-month and one two-month period
(see Figure 1).
Survey
Post implementation of the survey previously done in Phase
B will be repeated to explore changes in knowledge, atti-
tude, perceptions, current beliefs, and perceived practices
regarding delirium management of intensivists, physicians,
and ICU nurses from the participating ICUs [29,31,32].
Main outcome measures
The primary outcomes of the prospective before-after
pilot implementation study are adherence to screening
and (non)pharmacological treatment as described in the
Dutch ICU delirium guideline. Adherence to the delir-
ium screening procedure will be calculated as the per-
centage of performed assessments per day, relative to
the total number of assessments that should have been
performed (i.e. a minimum of three times daily in every
patient). Successful implementation is defined as adher-
ence to assessment of more than 85%. Delirium experts
(expert raters) will conduct accuracy spot-checks during
the intermediate and after periods on a random sample
of the bedside nurses’ screening assessments. The expert
will then share his or her findings from the CAM-ICU
or ICDSC assessment with the bedside nurse and point
out any mistakes or misconceptions in the nurse’s
assessment. Cohen’s kappa and 95% CIs will be used to
analyze agreement of CAM-ICU/ICDSC assessments be-
tween the bedside nurses and the delirium experts.
Adherence to the following aspects of non-pharmacological
and/or pharmacological interventions and prevention in-
terventions (based on the guideline) will be assessed:
a) pharmacological: prescription of antipsychotic drugs
(e.g. haloperidol); b) non-pharmacological: attention to
orientation, prevention of sleep deprivation, and the use
of glasses and hearing aids; and c) prevention: adher-
ence to early mobilization and physiotherapy. Data on
adherence indicators will be collected from systematic
Ista et al. Implementation Science 2014, 9:143 Page 6 of 10
http://www.implementationscience.com/content/9/1/143
registration in the patient data management system and
direct observations.
The secondary outcomes are the process measures (as
defined in the section process evaluation, e.g. incidence
of delirium; delirium knowledge of nurses and physi-
cians; interrater reliability of delirium assessment
(CAM-ICU or ICDSC); hospital mortality in the before,
intermediate, and after periods).
Other variables
During all measurement periods, data will be collected
on: psychoactive drugs (psychiatrist, neurologist, or
geriatrician consultations), complications (self-removal
of endotracheal tube, central lines, feeding tubes, and
falls out of bed) and length of ICU stay, length of hos-
pital stay, mortality, and institutionalization after hos-
pital discharge. These data are needed to explore a cost
benefit analysis of completed implementation. Further-
more, severity of illness scores (APACHE II score) and
ICU ward specialty (e.g. internal medicine, surgery, or
combined) will be retrieved from the Dutch National In-
tensive Care Evaluation (NICE) registry with consent
from the participating ICUs.
Analysis
Results are expressed as percentages. Adjusted analyses
will be done using repeated measures analysis for binary
outcome data. Finally, outcome differences between the
ICUs adjustments for patient mix (e.g. age, diagnosis,
APACHE II score) and ICU level will be assessed using
multi-variable analysis.
Sample size
Based on the literature, the adherence rate to screening
with the CAM-ICU or ICDSC could increase from 70%–
85%, following implementation [31,40]. Consequently, the
sample size will be 924 patients (231 patients in the before
period and 693 in the after period (3 periods, Figure 1)).
The alpha level of significance is set at 0.01 (two-tailed)
and the beta level at 0.90.
Process evaluation
A process evaluation can give insight into determinants
or indicators of potential success or failure of a tailored
implementation strategy [41,42]. For this purpose,
process data will be collected for each of substrategies
within the ‘tailored strategy’.
We will conduct in-depth qualitative interviews with
clinicians (n = 12) from participating ICUs to understand
their perceptions of the study’s effect on local practice
and the effectiveness of individual components of the
intervention. We will recruit these individuals by invita-
tion letters sent to all six ICUs. A semi-structured inter-
view guide will be developed to facilitate the interviews.
The process evaluation will provide insight in elements
of the tailored strategy that are less feasible and need
refinement before further implementation. In a post-
implementation survey, we will examine whether earlier
barriers are removed and facilitators are taken up.
Process measures
a. Education: number of nurses attending per ward,
duration of training per ward, evaluations of nurses
attending the training, experience with the training;
b. Tailored strategy: elements of the strategy are
delivered as agreed; feasibility of the strategy, user
experiences with the strategy, degree to which
barriers are solved, and facilitators are used.
Other process indicators will be defined after the strat-
egy procedure has been developed.
Data will be collected from questionnaires, interviews,
and direct observations. The process indicators will be
related to relevant outcomes (e.g. mortality reduction) of
the ‘tailored strategy’ to identify elements of the strategy
that were particularly associated with the success of the
implementation.
Economic evaluation
Prolonged admission on the ICU due to delirium is
related with increased health care costs. Therefore, strat-
egies that focus on increasing adherence with the Dutch
delirium guideline are likely cost-effective [15]. The eco-
nomic evaluation compares usual care (before) and care
after implementation of the guideline. The aim of this
analysis is to explore whether the likely overall cost sav-
ing from the tailored guideline implementation strategy
exceeds the overall cost of the tailored guideline imple-
mentation process.
Cost analysis
The economic evaluation will be performed from a
health care perspective and in accordance with guide-
lines for such analysis [43]. Care costs of each strategy
are defined as all direct medical costs associated with
procedures performed within that strategy. The re-
sources consumed by the implementation strategies will
be assessed in the clinical study by collecting data on
personnel costs (time spending for the strategy delivery
team, for the nurses attending the strategy related activ-
ities, and for systematic screening), material costs (anti-
psychotic drugs), and overhead costs. Medical costs will
be estimated by multiplying resource utilization with the
cost per unit of resource (market prices, guideline prices,
or self-determined prices based on costing methods, i.e.
full costing) [43]. The implementation process and con-
sequent costs will be estimated by focusing on activities
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performed with costs accumulated at the activity level(s)
of the health care implementation processes. The incre-
mental costs will be determined by the difference in
resource consumption between usual care and tailored
implementation. The economic analysis will be a cost-
minimalization analysis, in which we investigate whether
the likely overall cost saving from the tailored guideline
implementation strategy exceeds the overall cost of the
tailored guideline implementation process.
Ethical considerations
This study protocol was presented to the Medical Ethical
Committee of the Erasmus University Medical Center
(registration number: MEC-2012-063). An exemption
was obtained as ethical approval for this type of study is
not required under Dutch law. This study is registered
in the Trial register, located at http://clinicaltrials.gov,
under number: NCT01952899. Data collection will be in
line with Dutch METC endorsed privacy regulations,
ensuring that data collected for the analyses cannot be
traced to individual patients by the coordinating investi-
gators because the data will be anonymized by the local
investigators who provide the data.
Discussion
The goal of the iDECePTIvE study is to identify barriers
and facilitators for adherence to a national ICU delirium
guideline. We will analyze the current practice (Phase
A) before executing the survey and focus group inter-
views to avoid a possible Hawthorne effect (attention
effect) by which members of the focus groups could be
influenced. Based on these results, a tailored implemen-
tation strategy targeting these influencing factors will be
developed for successful implementation and long-term
adherence to the guideline. Finally, a before-after
multicenter study will be conducted to evaluate the im-
pact of the implementation strategy on clinical practice
including a cost-effectiveness analysis and the effects on
clinical outcomes.
This study is unique in that it includes all components
of a multifaceted implementation in a large cohort of
critically ill patients and includes measurement of im-
portant clinical outcomes based on a national database
benchmarking outcomes of intensive care in the
Netherlands. In a systematic review of the literature, we
found that ICU delirium implementation studies mainly
focus on implementation of screening or assessment
tools for early recognition of delirium in ICU patients
and tend to ignore improvement of prevention and
treatment [44]. Most implementation strategies were not
based on a systematic analysis of the context, including
barriers and facilitators. Studies have shown that large-
scale implementation of a delirium screening tool in the
ICU is both feasible and sustainable with a compliance
rate that may exceed 80% [31,40,45-47]. However, these
studies focused only on screening and not on pharmaco-
logical and non-pharmacological treatment of delirium.
Furthermore, the analysis of the barriers and facilitators
was unstructured and not focused on treatment as pro-
posed in the current delirium guideline. In this proposed
study, the multifaceted strategy will be based on theoret-
ically underpinned mechanisms to accomplish improved
adherence to a guideline on ICU delirium. A study in-
cluding all these components and of this magnitude has
not been performed previously. Also, outcome assess-
ments and cost-effectiveness analysis have not been per-
formed on this scale.
Furthermore, the results of this study will expectedly
provide us with further knowledge on effective imple-
mentation of optimal care of the delirious patient at the
ICU. We will provide answers to not only the ‘why
should we implement’ questions, but also answers to
‘how to implement’ question and provide clues to repro-
ducibility. In other words, the results of this study may
help persuade clinicians and nurses to put effort into
formal implementation of interventions, when indeed
the results confirm that these may improve outcomes of
our patients.
The results of this project will therefore add to the
general body of knowledge about implementation sci-
ence at the ICU. The knowledge generated from this
study can also be of use in other improvement projects
and guidelines in the ICU that require collaboration
between different health care providers [48,49].
A major limitation of this study with regard to the
clinical outcomes assessment (mainly: mortality) is the
before-after study design (phase D). Although changes
in team behavior and clinical practices (i.e. guideline ad-
herence; the primary outcome) related to delirium man-
agement during the course of this study are very likely
to be due to the implementation itself, changes in mor-
tality (secondary outcome) are less likely to be caused
exclusively by the implementation. Other factors besides
the implementation interventions that may impact on
mortality include case-mix changes over the course of
this study, changes in composition of the medical teams,
or organizational changes (e.g. rebuilding of ICU). Such
changes can only be partly accounted for in multivari-
able analysis because unmeasured (or unmeasurable)
confounders are potential sources for bias. Therefore, re-
sults of the pilot before-after study on clinical outcomes
rather than process measures should be interpreted with
great caution. The generalizability is limited because
concurrent changes in content or organization of care
that may influence clinical outcomes may confound at-
tribution of observed changes in outcomes to the imple-
mentation strategy. Furthermore, there is some evidence
that suggests that uncontrolled before-after studies may
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overestimate the effects of quality improvement projects
like this [24,50]. In future studies, a stepped wedge clus-
ter randomized trial would be a more sophisticated
design, in which at the end of the study all participants
will have received the intervention [51]. However, the
current study with the proposed design will provide
details regarding the feasibility of establishing practice
changes and guideline adherence improvements with a
tailored implementation and provide valuable informa-
tion on successful and less successful implementation in-
terventions and the need for their refinements in future
studies on a wider scale. Future implementation studies
aimed at improving outcomes will likely benefit from the
knowledge generated by our study because effective
interventions to change practice will be identified, which
is a first essential step towards outcome improvement.
We hypothesize that the incidence rates of delirium in
ICU patients will increase after implementation of early
screening. One of the main reasons is that hypoactive
delirium will be detected, which is ill-recognized without
systematic screening. On the other hand, implementation
of prevention and management of delirium is expected
to decrease incidences. The balance between these
opposite forces may explain why some studies found
decreased incidences and others increased incidences of
delirium after implementation of interventions targeted
at delirium. Therefore, we propose a two-phased imple-
mentation process (Phase D: first screening implemen-
tation, thereafter prevention and treatment). After data
collection for this reference period (before intermediate
period), guideline-recommended treatment will be imple-
mented. This approach prevents strong bias in the com-
parison of the incidence rates between the intermediate
and after periods because assessment of delirium before
and after implementation is similar.
The ultimate aim of our study is to reduce the inci-
dence of delirium and improve the outcome for ICU pa-
tients and their families by implementing the national
and international evidence-based guidelines on ICU de-
lirium management. Furthermore, this study provides a
framework for future efforts to stimulate guideline ad-
herence and delirium management.
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